IAG
Government Contracts & Awards
Proprietary Tech & Patents
SENSOR ASSEMBLY WITH WICKING MEMBER FOR LIQUID JUNCTION WET UP
ANTI-CSF-IR ANTIBODY
LYSIS, BINDING AND/OR WASH REAGENT FOR ISOLATING AND/OR PURIFYING NUCLEIC ACIDS
COMPOSITIONS AND METHODS FOR DETECTING PLASMODIUM SPECIES NUCLEIC ACID
Compositions and Methods for Nucleic Acid Quality Determination
Form D Funding
Private Placement
Private Placement
Private Placement
Market Intelligence & News
Labcorp Highlights Strategic Priorities Driving Durable Growth and Shareholder Value at 2026 Investor Day
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today will host its 2026 Investor Day at 9 a.m. ET, where the company will provide an in-depth review of its growth strategy, innovation roadmap and long-term financial outlook. The event will highlight Labcorp's unique position at the intersection of diagnostics, biopharma, science and technology and how the company is creating long-term value for customers and shareholders.
Apple Health app Users to be Able to Order Labs from Quest Diagnostics
Quest Diagnostics (NYSE: DGX) today announced that Apple Health app users in the United States1 will be able to conveniently purchase a tailored Quest laboratory test panel that includes over 50 biomarkers directly through the app on iPhone and iPad later this year. Apple first announced the upcoming update today at its September event.
Cognition AI valued at $48bn after $2bn Series E financing
Cognition AI created its autonomous coding agent Devin to help developer teams automate incident investigations and security vulnerability triage.
Quest Diagnostics CEO Sells 10,000 Shares for $2.4 Million
J. E. Davis disposed of 8% of his direct equity stake under a pre-planned Rule 10b5-1 trading arrangement, retaining $28.9 million in company stock.
UBS Maintains Neutral on Quest Diagnostics, Raises Price Target to $245
UBS analyst Kevin Caliendo maintains Quest Diagnostics (NYSE:DGX) with a Neutral and raises the price target from $232 to $245.
The Cure for Cancer is Becoming an Investable Opportunity: Analyst Sees $600 Million for Tempus AI
Personalized cancer vaccines are creating a diagnostics investment opportunity beyond Moderna and Merck, with tumor sequencing at its center.
Businesses bracing for potential tariff impact on foliage season
Plastic surgery is booming with boomers. Here’s how to cash in on the antiaging craze.
Americans age 65 and older are suddenly the fastest-growing customers for cosmetic surgery.
Whatever happened to the U.S. campaign to ban child marriage?
Living With Primary Immunodeficiency: How Specialty Care Supports Nick's Journey
* Diagnosed with primary immunodeficiency (PI) as an infant, Nick Stacken has spent decades pursuing his passions, including competing in Special Olympics. * Immunoglobulin (Ig) Therapy is often key to PI care, but ongoing support from pharmacists, nurses and caregivers can help patients build confidence and support their long-term health and personal goals.
Key People
No individuals linked to this entity yet.
Political Giving
$286,955 given to 63 candidates across 185 disclosed contributions (FEC Schedule A).
Lori Trahan
Scott H. Peters
Gus M. Bilirakis
Nanette Barragan
Darin McKay LaHood
Bradley S. Schneider
Earl Leroy Carter
John Cornyn
James E Hon Banks
Kim Schrier
Kathy Castor
Neal Patrick Dunn, MD, FACS
Adrian Smith
Terri A. Sewell
Thomas H. Kean
Ron Wyden
Rudy C. Yakym
Suzan K. DelBene
Frank Pallone
Elizabeth Fletcher
+ 43 more recipients not shown.
Factual Connections
Connections to other companies, executives, and politicians — sourced from disclosed trades, shared officers/directors, and public filings — are a Pro/Alpha feature.
Upgrade to Pro